Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer

NCT06591650 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Gallbladder Cancer Unresectable

Interventions

DRUG: gemcitabine hydrochloride
DRUG: Cisplatin
DRUG: Nab-paclitaxel
DRUG: Durvalumab

Sponsor

Fudan University